Cargando…

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction

AIMS: Vitamin D deficiency is prevalent in heart failure (HF), but its relevance in early stages of heart failure with preserved ejection fraction (HFpEF) is unknown. We tested the association of 25‐hydroxyvitamin D [25(OH)D] serum levels with mortality, hospitalizations, cardiovascular risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nolte, Kathleen, Herrmann‐Lingen, Christoph, Platschek, Lars, Holzendorf, Volker, Pilz, Stefan, Tomaschitz, Andreas, Düngen, Hans‐Dirk, Angermann, Christiane E., Hasenfuß, Gerd, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437442/ https://www.ncbi.nlm.nih.gov/pubmed/30784226 http://dx.doi.org/10.1002/ehf2.12413

Ejemplares similares

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2010)

Erratum to: Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2011)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
por: Bahls, Martin, et al.
Publicado: (2019)

Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study
por: Belyavskiy, Evgeny, et al.
Publicado: (2018)

Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany
por: Hashemi, Djawid, et al.
Publicado: (2020)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study
por: Gevaert, Andreas B., et al.
Publicado: (2022)

Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction
por: Kasner, Mario, et al.
Publicado: (2015)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study
por: Schertz, Anna, et al.
Publicado: (2019)

Left atrial function and maximal exercise capacity in heart failure with preserved and mid‐range ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2020)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Benini, Annachiara, et al.
Publicado: (2022)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Impact of Updated Guidelines on Diastolic Dysfunction in Patients with Preserved Ejection Fraction
por: Yoon, Hyun Ju
Publicado: (2021)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis
por: Morris, Daniel Armando, et al.
Publicado: (2017)

Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction
por: Bode, David, et al.
Publicado: (2021)

Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction
por: Liu, Dan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5gsknrfn6bro6m9mse45pe1qpe